Related Experiment Video
Updated: Apr 18, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Improved l-Cysteine Production in Corynebacterium glutamicum through Metabolic Engineering and High-Throughput
Guangying Li1,2,3, Yu Zou1,2,3, Ziming Fan1,2,3
1School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi 214122, China.
Metabolic engineering and a novel screening platform enhanced *Corynebacterium glutamicum* for l-cysteine production. This approach achieved a 4.04-fold increase in l-cysteine titer by overcoming metabolic toxicity and improving biosynthesis.
Area of Science:
- Microbial Biotechnology
- Metabolic Engineering
- Synthetic Biology
Background:
- l-Cysteine is a valuable amino acid with broad applications in food, pharmaceuticals, cosmetics, and animal feed.
- Corynebacterium glutamicum (C. glutamicum) is a preferred microbial chassis for l-cysteine synthesis due to its safety and metabolic control, but faces challenges in efficient production.
- Key limitations in C. glutamicum for l-cysteine production include product-associated metabolic toxicity and intricate regulatory networks, which perturb cellular redox homeostasis and limit metabolic flux.
Purpose of the Study:
- To overcome metabolic toxicity and enhance l-cysteine biosynthesis in C. glutamicum.
- To develop a high-throughput screening platform for identifying mutants with improved l-cysteine tolerance and production capabilities.
- To integrate rational metabolic engineering with evolutionary screening for microbial production optimization.
Main Methods:
- Metabolic engineering strategies were employed to optimize the l-cysteine synthesis pathway.
- A glycine-auxotrophic strategy was implemented to decouple one-carbon metabolism from product synthesis.
- A high-throughput screening platform was constructed, combining a biosensor, atmospheric and room-temperature plasma mutagenesis, and fluorescence-activated cell sorting.
Main Results:
- The developed screening platform effectively addressed the conflict between high production and high toxicity.
- Engineered strains exhibited enhanced tolerance and biosynthetic capacity for l-cysteine accumulation.
- The final engineered strain achieved an l-cysteine titer of 665 mg/L, a 4.04-fold increase compared to the pre-mutagenesis strain.
Conclusions:
- The integrated approach of rational design and evolutionary screening successfully overcame metabolic toxicity bottlenecks in microbial l-cysteine production.
- The high-throughput screening platform demonstrates powerful capability for mining and optimizing complex physiological regulatory traits.
- This study provides a robust framework for enhancing microbial production of high-value chemicals like l-cysteine.
Related Concept Videos
Bioreactor Controls-III
Production of Antibiotics
Production of Pharmaceuticals

